Prostate Cancer

May 15, 2005 Issue
Treatment Options for Prostate Cancer: Evaluating the Evidence [Article]

Controversy surrounds the management options for localized prostate cancer-conservative management, prostatectomy, and radiation. Choosing among these options is difficult because of long-term side effects that include sexual, urinary, and bowel dysfunction. Some recent studies suggest that patients...

Apr 1, 2004 Issue
Screening for Prostate Cancer [Putting Prevention into Practice]

Case study: DS, a 55-year-old African-American man, comes into your office for a physical examination. While talking about his family history, you learn that his father had prostate cancer. DS asks if he should be tested for prostate cancer.

Feb 15, 2003 Issue
Screening for Prostate Cancer [U.S. Preventive Services Task Force]

This is the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for prostate cancer and the supporting scientific evidence.

May 1, 2002 Issue
Neurologic Complications of Prostate Cancer [Article]

Neurologic complications continue to pose problems in patients with metastatic prostate cancer. From 15 to 30 percent of metastases are the result of prostate cancer cells traveling through Batson's plexus to the lumbar spine. Metastatic disease in the lumbar area can cause spinal cord compression. ...

Aug 15, 2000 Issue
AUA Issues a Policy Report on PSA Monitoring [Practice Guidelines]

The American Urological Association (AUA) has released a policy report on the use of prostate-specific antigen (PSA) in screening for and monitoring of prostate cancer.

Aug 01, 1998 Issue
Prostate Cancer Screening: More Harm Than Good? [Article]

The American Cancer Society and other national medical organizations emphasize the need for routine screening for prostate cancer in men over the age of 50. The serum prostate-specific antigen (PSA) assay is the test most commonly recommended for the purpose of screening. However, when PSA screening...

Apr 1, 1998 Issue
Diagnosis and Treatment of Prostate Cancer [Article]

In the United States, prostate cancer is the most common solid tumor malignancy in men and second to lung cancer as the leading cause of cancer deaths in this group. Even though prostate cancer is responsible for 40,000 deaths per year, screening programs are a matter of controversy because scientif...

Pages: Previous 1 2 3

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now